Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
PDEX 
Pro-Dex Inc (PDEX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/16/2025: PDEX (2-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $56
1 Year Target Price $56
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 28.74% | Avg. Invested days 32 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 09/16/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 107.87M USD | Price to earnings Ratio 12.36 | 1Y Target Price 56 |
Price to earnings Ratio 12.36 | 1Y Target Price 56 | ||
Volume (30-day avg) 1 | Beta -0.04 | 52 Weeks Range 25.01 - 70.26 | Updated Date 09/16/2025 |
52 Weeks Range 25.01 - 70.26 | Updated Date 09/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 2.64 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Earnings Date
Report Date 2025-09-04 | When After Market | Estimate 0.47 | Actual 0.36 |
Profitability
Profit Margin 13.48% | Operating Margin (TTM) 7.68% |
Management Effectiveness
Return on Assets (TTM) 11.76% | Return on Equity (TTM) 26.6% |
Valuation
Trailing PE 12.36 | Forward PE 13.89 | Enterprise Value 117291645 | Price to Sales(TTM) 1.62 |
Enterprise Value 117291645 | Price to Sales(TTM) 1.62 | ||
Enterprise Value to Revenue 1.76 | Enterprise Value to EBITDA 8.3 | Shares Outstanding 3261980 | Shares Floating 1816596 |
Shares Outstanding 3261980 | Shares Floating 1816596 | ||
Percent Insiders 35.94 | Percent Institutions 32.91 |
Upturn AI SWOT
Pro-Dex Inc
Company Overview
History and Background
Pro-Dex, Inc. was founded in 1978. It initially focused on manufacturing specialized rotary cutting and driving tools. Over time, it has evolved into a provider of precision rotary drive medical devices used in minimally invasive surgical applications.
Core Business Areas
- Medical Device Manufacturing: Designs, develops, manufactures, and markets powered surgical instruments and components, primarily for use in the orthopedic, trauma, and spine surgical markets.
- Industrial Products: Provides rotary cutting tools and other precision machined components for various industrial applications.
Leadership and Structure
Richard Van Kirk serves as the President and CEO. The company has a functional organizational structure with departments focusing on engineering, manufacturing, sales, and marketing.
Top Products and Market Share
Key Offerings
- Powered Surgical Instruments: Includes high-speed surgical drills, saws, and reamers used in orthopedic, spine, and trauma surgeries. Market share data is not publicly available, and revenue from this product is also not publicly available but it is Pro-Dex main offering. Key competitors include Stryker, Medtronic, and Zimmer Biomet.
- Rotary Cutting Tools: Specialized cutting tools used in various industrial applications, including aerospace and automotive. Market share data is not publicly available. Competitors include Kennametal, Sandvik, and OSG.
Market Dynamics
Industry Overview
The market for powered surgical instruments is growing due to increasing adoption of minimally invasive surgical techniques and an aging population. The industrial cutting tool market is influenced by economic cycles and technological advancements.
Positioning
Pro-Dex positions itself as a provider of high-precision, reliable surgical instruments and components. Its competitive advantage lies in its engineering expertise and ability to customize products to meet specific customer needs.
Total Addressable Market (TAM)
The global powered surgical instrument market is estimated to be around $4 billion. Pro-Dex's share of this market is relatively small, indicating significant growth potential. The rotary cutting tool market is substantial, estimated in the billions, where Pro-Dex occupies a niche market.
Upturn SWOT Analysis
Strengths
- Specialized Engineering Expertise
- Strong Customer Relationships
- Focus on High-Precision Products
- Vertically Integrated Manufacturing
Weaknesses
- Limited Brand Recognition
- High Customer Concentration
- Dependence on a Few Key Products
- Small Company, Susceptible to Economic Downturns
Opportunities
- Expanding into New Surgical Specialties
- Developing Innovative Surgical Instruments
- Acquiring Complementary Businesses
- International Expansion
Threats
- Competition from Larger Medical Device Companies
- Changes in Healthcare Regulations
- Technological Advancements Rendering Products Obsolete
- Economic Downturn Impacting Surgical Procedures
Competitors and Market Share
Key Competitors
- STRY
- MDT
- ZBH
Competitive Landscape
Pro-Dex faces competition from larger, more established medical device companies. Its advantages include specialized engineering and strong customer relationships, while its disadvantages include limited brand recognition and reliance on a few key customers.
Growth Trajectory and Initiatives
Historical Growth: Requires access to historical financial statements and revenue data.
Future Projections: Requires access to analyst reports and forecasts.
Recent Initiatives: Monitor company press releases and SEC filings for strategic initiatives.
Summary
Pro-Dex Inc. is a niche player in the surgical instrument market. Its strength lies in specialized engineering and manufacturing. However, its small size and reliance on key customers and products pose risks. Future growth depends on expanding into new markets and developing innovative products.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Industry Reports
Disclaimers:
This analysis is based on publicly available information and may not be complete. Market share estimates are approximate. Financial data is unavailable and needs to be externally sourced.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Pro-Dex Inc
Exchange NASDAQ | Headquaters Irvine, CA, United States | ||
IPO Launch date 1995-08-18 | CEO, President & Director Mr. Richard Lee Van Kirk Jr. | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 179 | Website https://www.pro-dex.com |
Full time employees 179 | Website https://www.pro-dex.com | ||
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.